iBio, Inc. SEC filings IBIO
iBio, Inc. has 909 filings in SEC EDGAR's recent list, going back to Mar 7, 2008. Its latest annual report, Form ARS, was filed on Sep 4, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Sep 4, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Aug 28, 2026 | Jun 30, 2026 |
| ARS | Annual report to shareholders | Oct 6, 2025 | Jun 30, 2025 |
| 10-K | Annual report | Sep 5, 2025 | Jun 30, 2025 |
| ARS | Annual report to shareholders | Oct 10, 2024 | Jun 30, 2024 |
| 10-K/A | Amended annual report | Sep 24, 2024 | Jun 30, 2024 |
| 10-K | Annual report | Sep 20, 2024 | Jun 30, 2024 |
| ARS | Annual report to shareholders | Oct 26, 2023 | Jun 30, 2023 |
| 10-K | Annual report | Sep 27, 2023 | Jun 30, 2023 |
| 10-K | Annual report | Oct 11, 2022 | Jun 30, 2022 |
| 10-K | Annual report | Sep 28, 2021 | Jun 30, 2021 |
| 10-K/A | Amended annual report | Oct 27, 2020 | Jun 30, 2020 |
| 10-K | Annual report | Oct 13, 2020 | Jun 30, 2020 |
| 10-K | Annual report | Aug 26, 2019 | Jun 30, 2019 |
| 10-K | Annual report | Sep 18, 2018 | Jun 30, 2018 |
| 10-K | Annual report | Sep 15, 2017 | Jun 30, 2017 |
| 10-K | Annual report | Oct 13, 2016 | Jun 30, 2016 |
| 10-K | Annual report | Oct 13, 2015 | Jun 30, 2015 |
| 10-K/A | Amended annual report | Oct 28, 2014 | Jun 30, 2014 |
| 10-K | Annual report | Sep 29, 2014 | Jun 30, 2014 |
| 10-K/A | Amended annual report | Nov 4, 2013 | Jun 30, 2013 |
| 10-K/A | Amended annual report | Oct 4, 2013 | Jun 30, 2013 |
| 10-K | Annual report | Sep 30, 2013 | Jun 30, 2013 |
| 10-K/A | Amended annual report | Oct 15, 2012 | Jun 30, 2012 |
| 10-K | Annual report | Oct 12, 2012 | Jun 30, 2012 |
| 10-K | Annual report | Sep 29, 2011 | Jun 30, 2011 |
| 10-K/A | Amended annual report | Nov 24, 2010 | Jun 30, 2010 |
| 10-K | Annual report | Oct 13, 2010 | Jun 30, 2010 |
| 10-K | Annual report | Sep 28, 2009 | Jun 30, 2009 |
| 10-K/A | Amended annual report | Oct 28, 2008 | Jun 30, 2008 |
| 10-K | Annual report | Sep 29, 2008 | Jun 30, 2008 |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IBIO (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1420720
- Former names
- iBio, Inc. (until Oct 19, 2026); iBioPharma, Inc. (until Aug 14, 2009); InB:Biotechnologies, Inc. (until Jul 17, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.